The Report Global Depression Drugs Market 2015-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
About depression drugs
According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are more likely to be affected by depression than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating disorders in the US and affects about 14.80 million adults aged 18 years and above.
View Full Report at http://www.marketresearchreports.biz/analysis/287684
Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below:
Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors
Others
Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/287684
Key regions
Americas
APAC
EMEA
Key vendors
Actavis
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Pfizer
Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Alkermes
AstraZeneca
Aurobindo Pharma
Avanir Pharmaceuticals
Cerecor
Chugai Pharmaceutical
Dart NeuroScience
Dr. Reddy's Laboratories
Edgemont Pharmaceuticals
E-Therapeutics
Euthymics
Evotec
F. Hoffmann-La Roche
Fabre Kramer
Gedeon Richter
H. Lundbeck
Intra-Cellular Therapies
Janssen Pharmaceuticals
Lupin
Luye Pharma
MSI Methylation Sciences
Naurex
Neuralstem
Novartis
Opko Health
Otsuka Pharmaceutical
Pierre Fabre
Shire
SK Biopharmaceuticals
Somerset Pharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals
Suven
Takeda Pharmaceutical
Teva Pharmaceutical
Torrent Pharmaceuticals
Valeant Pharmaceuticals
Market driver
Rise in patient population
For a full, detailed list, view our report
Market challenge
Threat of expiry of patents
For a full, detailed list, view our report
Market trend
Growing public awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Table Of Content
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Product Profiles
04.1.1 Celexa
04.1.2 Fetzima
04.1.3 Lexapro
04.1.4 Viibryd
04.1.5 Cymbalta
04.1.6 Prozac
04.1.7 Symbyax
04.1.8 Paxil
04.1.9 Wellbutrin
04.1.10 Abilify
04.1.11 Effexor
04.1.12 Pristiq
04.1.13 Zoloft
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Disorder Overview
07.1 Types of depression
About MarketResearchReports.biz
Marketresearchreports.biz ( http://www.marketresearchreports.biz) is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.
Contact:
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
About depression drugs
According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are more likely to be affected by depression than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating disorders in the US and affects about 14.80 million adults aged 18 years and above.
View Full Report at http://www.marketresearchreports.biz/analysis/287684
Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below:
Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors
Others
Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/287684
Key regions
Americas
APAC
EMEA
Key vendors
Actavis
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Pfizer
Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Alkermes
AstraZeneca
Aurobindo Pharma
Avanir Pharmaceuticals
Cerecor
Chugai Pharmaceutical
Dart NeuroScience
Dr. Reddy's Laboratories
Edgemont Pharmaceuticals
E-Therapeutics
Euthymics
Evotec
F. Hoffmann-La Roche
Fabre Kramer
Gedeon Richter
H. Lundbeck
Intra-Cellular Therapies
Janssen Pharmaceuticals
Lupin
Luye Pharma
MSI Methylation Sciences
Naurex
Neuralstem
Novartis
Opko Health
Otsuka Pharmaceutical
Pierre Fabre
Shire
SK Biopharmaceuticals
Somerset Pharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals
Suven
Takeda Pharmaceutical
Teva Pharmaceutical
Torrent Pharmaceuticals
Valeant Pharmaceuticals
Market driver
Rise in patient population
For a full, detailed list, view our report
Market challenge
Threat of expiry of patents
For a full, detailed list, view our report
Market trend
Growing public awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Table Of Content
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Product Profiles
04.1.1 Celexa
04.1.2 Fetzima
04.1.3 Lexapro
04.1.4 Viibryd
04.1.5 Cymbalta
04.1.6 Prozac
04.1.7 Symbyax
04.1.8 Paxil
04.1.9 Wellbutrin
04.1.10 Abilify
04.1.11 Effexor
04.1.12 Pristiq
04.1.13 Zoloft
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Disorder Overview
07.1 Types of depression
About MarketResearchReports.biz
Marketresearchreports.biz ( http://www.marketresearchreports.biz) is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.
Contact:
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
No comments:
Post a Comment